Objectives
Acute coronary syndrome is emergent in coronary heart disease with high morbidity and mortality. Over the last decade, large magnitude of evidence from large-scale clinical trials have tested the efficacy of using intensive dose of statin at the early stage of acute coronary syndrome which would reduce incidence of cardiovascular events and increase survival rate.The guidelines for management of dyslipidaemias in Amenrica and Europe have recommended intensification of statin therapy for acute...